glp 1 for menopausal women 20% of ages 50-64 have used GLP-1's making perimenopausal and women the TOP users of these drugs. Read more in this very informative article: https://www.rand.org/pubs/research_reports/RRA4153-1.html GLP-1 Weight Loss in Menopause:

Problems It Addresses

Semaglutide produced less weight loss than tirzepatide head-to-head, about 14% versus 20%. Its body-composition substudy measured a roughly 62:38 fat-to-lean loss split by mass, compared with about 75:25 for tirzepatide in a separate trial. The scan overstates muscle loss because lean mass includes water and organ tissue

Pairing TMG with NAD+, using reduced glutathione instead of cheaper oxidized forms, these are decisions that most of the supplement industry hasn't caught up to yet

Wear PPE including gloves, lab coat, and protective eyewear Handle compounds within approved laboratory workspaces Avoid inhalation, ingestion, or direct contact Dispose of materials according to institutional chemical waste procedures Maintain proper labeling and documentation for stored research compounds These practices support safe and compliant laboratory operations